Moderna has been chosen to be used for the inoculation of employees of South Korea’s top tech companies, including Samsung, LG, and SK Group. This information was revealed on Wednesday, June 9.
As per The Korea Herald, the S. Korean government has reserved Moderna COVID-19 vaccines for workers of major companies, and it is now preparing to distribute the vials to them in an effort to help businesses get back to normal operations as early as possible.
The inoculation for the leading firms in S. Korea
Based on the reports, the country’s Ministry of Employment and Labor already distributed a guide to firms on how the COVID-19 vaccine will be sent out and scheduled for their workers to receive the doses. Those that received the guide are Samsung Electronics, LG Group, and SK, also included in this guideline are the firms’ affiliates.
The guide was to allow the ministry to determine the amount of Moderna doses that the companies will need to have all of their workers inoculated. This vaccination program is said to be a strategic plan for industries that operate factories and have their own in-house clinics.
Since they have their own facilities, the vaccination will be easier since they can just get their schedules for the jab in their own clinics. It was revealed that the government may have to allocate more than 200,000 Moderna shots as in Samsung Electronics alone, it needs about 100,000 vaccine doses already.
“Employees who want to get the Moderna shots were told to submit applications,” an industry insider told the media outlet. “However, there is no confirmed administration schedule yet.”
For SK and LG, they are confirmed for Moderna jabs too and were already contacted by the government as well. "SK Hynix is considering measures to follow the government guideline regarding the vaccination," a company official stated.
S.Korea approves Moderna vaccine
Meanwhile, South Korea approved Moderna vaccines only last month, as per Reuters. The nation’s drug safety minister Kim Gang Lip confirmed that the American version of the COVID-19 vaccine was greenlighted in an effort to speed up the vaccinations.
Finally, it was revealed that three experts have participated in the Moderna review, and they recommended for the shots to be approved for two-dose inoculations.


Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Asian Markets Slip as AI Spending Fears Shake Tech, Wall Street Futures Rebound
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Australia’s December Trade Surplus Expands but Falls Short of Expectations
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off
U.S. Stock Futures Edge Higher as Tech Rout Deepens on AI Concerns and Earnings
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 



